Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2006-10-16Clinical Trial Update: Prevalence of COPD: First Epidemiological Data From a Large Region of Turkey
An epidemiological update reporting the first prevalence data for chronic obstructive pulmonary disease from a large region of Turkey, based…
-
CLINICAL_TRIALS trial_result · 2006-10-13Clinical Trial Update: A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD [Phase 1, Phase 2]
Pfizer conducted a Phase 1/2 study to evaluate the safety and efficacy of UK-369,003 in patients with chronic obstructive pulmonary disease.…
-
CLINICAL_TRIALS research · 2006-10-13Clinical Trial Update: Anticipatory & Preventive Team Care (APTCare): At Risk Patients of Family Health Networks [Phase 2, Phase 3]
An update on the Phase 2 and Phase 3 trial Anticipatory & Preventive Team Care (APTCare) for at-risk patients within Family Health Networks,…
-
FDA approval · 2006-09-20FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for SPIRIVA HANDIHALER (tiotropium bromide) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2006-09-15FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for XOPENEX HFA (levalbuterol tartrate). The approval relates to changes descri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-09-12Clinical Trial Update: Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 trial evaluating inhaled carbon monoxide to modify chronic inflammation in patients with stable COPD. The trial status is COMPLETED.
-
CLINICAL_TRIALS research · 2006-09-11Clinical Trial Update: Investigation on the Role of Corticosteroids and Beta-Agonists on Cytokine Production in COPD Patients
A clinical trial investigating how corticosteroids and beta-agonists influence cytokine production in patients with chronic obstructive pulm…
-
FDA approval · 2006-09-05FDA Approved: ATROVENT HFA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for ATROVENT HFA (ipratropium bromide) from Boehringer Ingelheim Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2006-08-29Clinical Trial Update: Hospitalization at Home of Elderly Patients With Exacerbated COPD [NA]
A completed clinical trial evaluating hospitalization at home for elderly patients with exacerbated chronic obstructive pulmonary disease (C…
-
CLINICAL_TRIALS trial_result · 2006-08-21Clinical Trial Update: Inspiratory Muscle Training in Hypercapnic COPD [Phase 4]
Clinical trial update on a Phase 4 study of inspiratory muscle training for patients with COPD with hypercapnia and respiratory failure.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 trial evaluating osteopathic manipulation therapy for emphysema/COPD reports efficacy results.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD) [Phase 1, Phase 2]
An NCCIH-sponsored trial evaluated yoga as a non-pharmacologic approach to alleviate shortness of breath in chronic obstructive pulmonary di…
-
FDA approval · 2006-07-21FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved the original application for budesonide and formoterol fumarate dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP, a co…
-
FDA approval · 2006-06-08FDA Approved: ADVAIR HFA — Original Application (GlaxoSmithKline LLC)
This document records the original FDA approval of Advair HFA, a combination inhaled therapy of fluticasone propionate and salmeterol xinafo…
-
CLINICAL_TRIALS trial_result · 2006-05-29Clinical Trial Update: Sodium Pyruvate Therapy in COPD Patients [Phase 2]
Phase 2 trial of sodium pyruvate therapy for chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS research · 2006-05-18Clinical Trial Update: COPD Rehabilitation in Primary and Secondary Health Care
This document is a clinical trial update for a COPD rehabilitation program in primary and secondary health care. The sponsor is Glostrup Uni…
-
CLINICAL_TRIALS trial_result · 2006-05-16Clinical Trial Update: A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD [Phase 2]
A Phase 2 clinical trial evaluating multiple doses of AD 237 in adults with chronic obstructive pulmonary disease has completed, assessing s…
-
CLINICAL_TRIALS trial_result · 2006-05-15Clinical Trial Update: Multidisciplinary Inpatient Palliative Care Intervention [NA]
A completed clinical trial evaluating a multidisciplinary inpatient palliative care intervention; the snippet notes status (COMPLETED) and p…
-
CLINICAL_TRIALS trial_result · 2006-05-10Clinical Trial Update: Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy [Phase 2]
A Phase 2 trial of azithromycin in patients with chronic obstructive pulmonary disease and tracheostomy was terminated.
-
CLINICAL_TRIALS trial_result · 2006-05-09Clinical Trial Update: Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial [Phase 4]
A Phase 4 randomized trial is evaluating whether Advair (fluticasone propionate/salmeterol) and Flovent (fluticasone propionate) can reduce …